购物车
- 全部删除
- 您的购物车当前为空
Ro 08-2750 是一种非肽和可逆的神经生长因子 (NGF) 抑制剂,与 NGF 结合,IC50 约为 1 µM。它是一种选择性 MSI RNA 结合活性抑制剂,IC50 为 2.7 μM。它选择性抑制 NGF 与 p75NTR 的结合,而不是 TRKA。
为众多的药物研发团队赋能,
让新药发现更简单!
Ro 08-2750 是一种非肽和可逆的神经生长因子 (NGF) 抑制剂,与 NGF 结合,IC50 约为 1 µM。它是一种选择性 MSI RNA 结合活性抑制剂,IC50 为 2.7 μM。它选择性抑制 NGF 与 p75NTR 的结合,而不是 TRKA。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 235 | 现货 | |
5 mg | ¥ 594 | 现货 | |
10 mg | ¥ 967 | 现货 | |
25 mg | ¥ 1,939 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 664 | 现货 |
产品描述 | Ro 08-2750 is a non-peptide and reversible nerve growth factor (NGF) inhibitor which binds to NGF, and with an IC50 of ~ 1 µM. Ro 08-2750 is a selective MSI RNA-binding activity inhibitor, with an IC50 of 2.7 μM. Ro 08-2750 inhibits NGF binding to p75NTR selectively over TRKA. |
靶点活性 | NGF:~1 μM |
体外活性 | Ro 08-2750 inhibits the survival of human AML lines and patient cells. Ro 08-2750 suppresses MSI2 RNA-binding and alters the MSI2 gene signature. Ro 08-2750 binds to the NGF dimer thereby probably inducing a change in its conformation such that NGF cannot bind to p75NTR anymore. Ro 08-2750 (5-10 μM; 8 hours) increases differentiation and apoptosis in myeloid leukemia cells. Ro 08-2750 (10 nM) fully rescues cells from undergoing NGF-induced SK-N-MC 103 cell death [2][3]. |
体内活性 | In a myeloid leukemia model in vivo, Ro 08-2750 (13.75 mg/kg; i.p.) suppresses leukemogenesis [3]. |
分子量 | 270.24 |
分子式 | C13H10N4O3 |
CAS No. | 37854-59-4 |
Smiles | Cc1cc2nc3c(nc(=O)[nH]c3=O)n(C)c2cc1C=O |
密度 | 1.57g/cm3 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 3.5 mg/mL (12.95 mM), Sonication and heating to 80℃ are recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
|
评论内容